- Research article
- Open Access
Discovering multiple transcripts of human hepatocytes using massively parallel signature sequencing (MPSS)
BMC Genomics volume 8, Article number: 207 (2007)
The liver is the largest human internal organ – it is composed of multiple cell types and plays a vital role in fulfilling the body's metabolic needs and maintaining homeostasis. Of these cell types the hepatocytes, which account for three-quarters of the liver's volume, perform its main functions. To discover the molecular basis of hepatocyte function, we employed Massively Parallel Signature Sequencing (MPSS) to determine the transcriptomic profile of adult human hepatocytes obtained by laser capture microdissection (LCM).
10,279 UniGene clusters, representing 7,475 known genes, were detected in human hepatocytes. In addition, 1,819 unique MPSS signatures matching the antisense strand of 1,605 non-redundant UniGene clusters (such as APOC1, APOC2, APOB and APOH) were highly expressed in hepatocytes.
Apart from a large number of protein-coding genes, some of the antisense transcripts expressed in hepatocytes could play important roles in transcriptional interference via a cis-/trans-regulation mechanism. Our result provided a comprehensively transcriptomic atlas of human hepatocytes using MPSS technique, which could be served as an available resource for an in-depth understanding of human liver biology and diseases.
The liver – one of most important organs in the human body – performs the main digestive function in the metabolism of most substances. In addition, liver has a number of other functions, including the generation of red blood cells during embryonic development, production of various plasma proteins, detoxification of xenobiotics and phagocytosis of solid materials. It forms a protective barrier between the digestive tract and the rest of the body. The liver also plays a vital role in activation, catabolism and excretion of retinols that are essential to the vision, growth, reproduction, immunity, cell proliferation and differentiation of the body. Furthermore, as a major organ of drug elimination, the liver has a significant effect on drug metabolism. However, to date the molecular mechanisms of liver function have not been completely characterized.
Massively Parallel Signature Sequencing (MPSS) as a global view with no bias towards the transcriptome of certain tissues or cells will provide a profound understanding of organ and cell functions [1, 2]. It is well known that human liver is composed of many types of cells, such as hepatocytes, bile duct cells and kupffer cells, where hepatocytes account for three-quarters of the volume and perform the main functions of the liver. In this study, a powerful transcriptomic approach was employed to profile the gene expression of human hepatocytes obtained by laser capture micro dissection (LCM) for providing an available resource to address the molecular basis of hepatocyte biology.
Results and Discussion
Identification of UniGene clusters in hepatocytes by MPSS
First, human hepatocytes were obtained from the ten samples using LCM. To eliminate the variation between individuals, we extracted the total RNA from these individual samples and assessed by the Agilent 2100 Bioanalyzer, and then RNAs were equally pooled. The pooled RNA from the LCM samples was available for analysis in following steps. To further evaluate the quality of RNA sample isolated from the hepatocytes, reverse transcription (RT)-PCR was employed to detect the expression of the hepatocyte-specific marker, albumin (ALB), and the bile duct cell-specific marker, cytoskeleton protein 19 (CK19). The resulting data showed that ALB was significantly expressed in the hepatocytes (Figure 1A, upper), whereas CK19 was detected in liver but not in the hepatocytes (Figure 1A, bottom), indicating that the hepatocytes captured by LCM were pure and appropriate for the transcriptomic analysis.
The pooled RNA was then subjected to MPSS analysis (TaKaRa Co., Japan). 60,635 distinct signatures that represent different transcripts were derived from a total of 2,990,779 sequences in four sequencing runs. The sequencing runs were merged and the expression level of each signature was normalized to transcripts per million (TPM), essentially as previously described by Meyers et al [1–3]. To annotate the signatures, the distinct signatures were searched against human UniGene database (UniGene Build 184, Homo sapiens) and the human genome sequences (hg17) by BLAST programs. Similar to the annotation process developed by Lynx, each signature was ranked based on its position and orientation within the transcript, the presence of a polyadenylation signal and polyA tail in the transcript sequence (see additional file 1). Herein, the expression value (TPM) of each gene is the sum of all TPMs of signatures matched to this gene. Out of the 60,635 signatures, 92.3% and 6.5% were detected in the range of 1–9 and 10–99 TPM, respectively. Only 1.2% of the signatures exhibited the high TPMs over 100 (Table 1), in which ALB (97934 TPMs), known to be secreted by hepatocytes, showed the highest abundance. Overall, the abundances of MPSS signatures indicated that a large number of genes were expressed at lower levels in hepatocytes, whereas only a few genes were expressed at very high levels.
To describe the detailed profiles of gene expression of hepatocytes, 60,635 signatures from MPSS data were first compared with UniGene database. The resulting data indicated that 19,435 (32.05%) signatures were uniquely matched with 10,279 non-redundant UniGene clusters, whereas 7,223 (11.91%) signatures could not be defined as unique UniGene clusters due to multiple hits with UniGene dataset. The remaining 33,977 signatures were then employed to be searched against a human genomic database. 15,807 (26.07%) signatures were uniquely mapped onto specific genomic loci, whereas 11,614 (19.15%) hit multiple genomic sequences (Table 2). In addition, 2,229 (3.68%) signatures matched with over 100 genome locations. 4,327 (7.14%) signatures could not be matched to any known genomic sequences, possibly due to sequencing errors, spliced 3'-ends that have not yet been identified, and transcripts in regions of the genome not yet sequenced [4, 5]. Alternatively, the reasons why signatures may not match the genome may be that the signatures contain part of a poly(A) tail, or polymorphisms between the individual(s) analysed and the reference human genome sequence, or contamination with RNA or DNA from other species. Also, the use of BLAST to match signatures to the genome may preclude the identification of single nucleotide mismatches between the sequence and the genome or transcriptome databases.
To evaluate whether those signatures with low abundance (≤ 3 TPMs) were also reliably expressed in the hepatocytes, RT-PCR was employed to detect the transcripts of the 16 UniGene clusters with less than 3 TPMs, where the UniGenes were randomly selected for the estimation. The interesting results showed that the transcripts of all UniGene clusters examined were indeed detected in the human hepatocytes at different levels (Figure 1B), suggested that transcripts detected at 3 TPMs or less by MPSS assay could in fact be proven to be expressed by RT-PCR.
Taken together, the resulting data suggested that 10,279 UniGene clusters could be detected in human hepatocytes using MPSS technique, implying that 7,475 known genes represented by the MPSS signatures could be expressed in the cell type of liver (see additional file 2).
Enriched genes in hepatocytes
To explore the enriched genes expressed in human hepatocytes, we compared the hepatocyte MPSS dataset with datasets from another 32 tissues deposited in GEO . We clustered all genes with hierarchical clustering by using Genespring Software (Figure 2). The resulting data showed that there were many genes enriched in hepatocytes. To identify the enriched genes in hepatocytes, the following formula was used as previous description :
Here S is the enrichment, E1 to En are the expression levels across all tissues and Eh is the expression value observed in hepatocytes for a given gene. S values > 2 would be considered as hepatocyte-enriched genes. The results indicated that 327 non-redundant UniGene clusters were enriched in hepatocytes (see additional file 3). Many of these were well-known to be secreted by hepatocytes and enriched in the liver. For example, ALB, APOA, APOB, and APOC are related to lipid metabolism and maintaining the balance of proteins in plasma. Interestingly, a number of genes with unknown functions, such as FLJ32745 and MGC40405, were also enriched in hepatocytes. Whether these genes are involved in hepatic functions should be further investigated. However, it should be pointed out that the distinct discrepancy of gene expression profiles between liver and other human tissues, based on hierarchical clustering of MPSS data (Figure 2), might result partially from the technical difference between the data collected in this study and the reference dataset.
These 327 hepatocytes-enriched genes were mapped onto human chromosomes based on genomic information (GeneMap'99). Some hepatocyte-enriched UniGene clusters were mapped onto certain gene-rich regions, such as 8q24, 11p15.5, 11q13.1, 16p13.3, 17q25.1 and 19 (Figure 3). To further characterize the regulatory mechanisms of the genes enriched in hepatocytes, the most over-represented motifs of the promoters of these hepatocyte-enriched genes (S _value more than 2), as compared to that of those non-hepatocyte-enriched genes (S _value less than -2), were identified in silico by the Motifclass program . The top ten over-represented motifs included NR1H3, SMAD, NERF1a, and HNF4, where the corresponding sequence logo builds were derived from the position weight matrix (PWM) for the motifs (Figure 4). Among them, HNF4 – one of the best experimentally known motifs in human liver – has been reported to play an important role in gene regulation networks in liver [8, 9]. The data suggested that these cis-regulatory elements and their corresponding transcription factors might be crucial to the expression pattern of the hepatocyte-enriched genes.
Natural antisense transcripts (NATs) have been identified from plants  and animals , and these antisense RNAs are thought to be very important in the regulation of gene expression in such higher eukaryotes [11, 12]. Recently, approximately 5000 UniGene clusters of potential human NAT pairs had been identified by several groups [13–15]. The synchronous presence of both sense and antisense transcripts in the same cells or tissues may be an important indicator of antisense regulation [16, 17]. Interestingly, among 19,435 signatures uniquely matched with UniGene clusters, we here identified 1,819 unique signatures matching antisense strands according to the signature classification (see additional file 1 and 4), according to the previous description by Jongeneel et al . Herein, these antisense strands represented 1,605 non-redundant cis-antisense transcripts in hepatocytes, of which 1,127 (70.2%) of these antisense transcripts are co-expressed with their corresponding sense transcripts, whereas 478 (29.8%) of these antisense transcripts were found to be expressed alone. Compared with published NATs, 1,222 out of 1,605 UniGene clusters of the antisense transcripts were previously uncharacterized, implying that a large number of NATs could be found in given cells or tissues by the powerful transcriptomic approach.
To further characterize the functional features of those genes with antisense transcripts expressed in human hepatocytes, these genes were assigned into GO functional categories. The majority of these genes were classified into the categories of basic metabolism, cell growth and/or maintenance, and cell communication, whereas a few genes were associated with liver development, morphogenesis, cell differentiation, and cell death (Figure 5A). To define whether a GO category is really over- or under-represented in genes with antisense transcripts, we here performed the FatiGO+ classification, a web-based tool for the functional profiling of GO categories, through comparing the subcategories for genes with or without detectable antisense transcripts. Interestingly, the resulting data suggested that some GO subcategories related to molecular functions, such as the activity of vascular endothelial growth factor receptor, arylamine N-acetyltransferase, MAP kinase kinase kinase and chemokine receptor, were significantly over-represented in genes with antisense transcripts (p < 0.05), whereas the category associated with ATPase activity were under-represented in genes with antisense transcripts (p < 0.05) (Figure 5B), suggesting that NATs could be involved in the regulation of hepatocyte functions. Both sense and antisense transcripts of some genes that are related to liver function were found to be co-expressed in hepatocytes. For example, some apolipoproteins (apo), including APOC1, APOC2, APOB and APOH that constitute the essential structural proteins of certain lipoproteins involved in lipid transport, were found to exhibit both sense and antisense transcripts co-expressed in hepatocytes. To confirm the existence of the antisense transcripts, specific primers against these genes were designed for RT-PCR (Figure 5C), where two genes, TMEM37 and LASS5, without antisense counterparts detected by MPSS, were randomly selected as negative control in the RT-PCR approach. The RT-PCR data showed that the antisense transcripts of APOC1, APOC2, APOB and APOH are indeed co-expressed with their corresponding sense transcripts in hepatocytes (Figure 5D), whereas the antisense counterparts of TMEM37 and LASS5 were not detected, although the sense transcripts of these two genes were expressed (Figure 5D), which was in consistence with the MPSS data. These interesting results, that the antisense transcripts of some genes were in fact co-expressed with the sense ones, suggested that the post-transcriptional regulation at mRNA level of some genes could be an important event through degenerating the sense RNAs or editing the mRNA for generating different splicing [18–20].
To further characterize the antisense transcripts' tissue enrichment, the NATs data from the hepatocytes was compared with that of published MPSS data from another 32 tissues . Here, NATs were considered as tissue-enrichment where the S_value was > 2. Many NATs exhibited significant tissue-enriched expression patterns (Figure 6) (see additional file 5), suggesting that the expression of these NATs could be strictly regulated in a given tissue. Among 93 potential hepatocyte-enriched NATs (see additional file 6), some antisense transcripts may be involved in pentose and glucuronate interconversions (DCXR, UGT2B4 and UDP), fatty acid metabolism (EHHADH), bile acid biosynthesis (BAAT), urea cycle (CPS1), and arachidonic acid metabolism (CYP2C8, CYP2C9, CYP2E1 and AKR1C3).
To explore the genetic mechanisms involved in the regulation of these NATs, all NATs were mapped onto the genomic loci in order to investigate the genomic features of their corresponding sense transcripts. Among 1,819 NATs, 1,049 NATs were uniquely mapped onto genomic loci, where 507 (48.33%) were matched onto the exons of the corresponding genes, including 106 (10.11%), 142 (13.54%), and 259 (24.69%) assigned onto 5'-UTR, 3'-UTR, and protein-encoding regions, respectively, according to the structures of mRNAs derived from these genes (Figure 7A). Furthermore, additional 46 (4.38%) and 496 (47.28%) NATs were localized onto the promoters and intronic regions of genes, respectively, implying that the regulatory mechanisms of transcriptional expression involving antisense RNAs are very complex, although the possibility that these NATs are polyadneylated in the opposite direction of the sense strand transcripts does not exclude. Interestingly, of 46 NATs matched to the promoters, 16 could be transcribed from the CpG island-enriched promoters (Figure 7B, see additional file 7). Recently, some groups have reported that the association of antisense RNA transcripts with CpG methylation can lead to human genetic diseases [20, 21]. Whether these NATs in hepatocytes could regulate the transcriptional efficiency of sense transcripts through the DNA methylation of the promoters should be further investigated.
To evaluate the evolutional conservation of these NATs, we identified their ortholog pairs between human and mouse through the reciprocal best matches between both genomes. 167 (10.40%) out of 1,605 human NATs were considered to have the corresponding antisense orthologs from mouse through comparing the data from the HomoloGene database with Mouse Genome Informatics, suggesting that some NATs could be evolutionarily conservative. Furthermore, these human NATs derived from hepatocytes were compared with 1,127 mouse NATs from the liver based on MPSS signatures deposited in NCBI GEO (GPL1010). The resulting data showed that 167 NATs, including 146 with both sense and antisense transcripts, were commonly expressed in human and mouse livers (see additional file 8). For example, the NATs of these genes, such as CYP4A2, HADH2, HSD17B4 and ACOX2 involved in fatty acid metabolism, CYP27A1 and ACADSB in bile acid biosynthesis, and ADH4 in alcohol metabolism, were conserved in both human and mouse livers, suggesting that these conservatively co-expressed sense-antisense pairs could play important roles in hepatic functions.
This study provided a comprehensively transcriptomic atlas of human hepatocytes using MPSS technique, which could be served as an available resource for an in-depth understanding of human liver biology and diseases. In addition, the data suggested that, like a large number of protein-coding genes, some antisense transcripts expressed in hepatocytes could play important roles in transcriptional interference via cis-/trans-regulation mechanisms.
Adult human livers
Normal human livers from ten patients were resected surgically because of hemangioma in liver in China. The samples were obtained from the portion unaffected by the hemangioma and frozen in liquid nitrogen immediately. All procedures and risks were explained verbally and in a written consent form. The samples were sectioned and confirmed to be normal histologically. All laboratory data assessing hepatic function were within normal ranges, including serum alanine aminotransferase, aspartate aminotransferase, g-glutamyl transpeptidase, alkaline phosphatase, total bilirubin, albumin, prothrombin activity, glucose, cholesterol, and triglycerides (data are not shown). Serological tests for hepatitis B surface antigen, Hepatitis C virus antibodies, and Human immunodeficiency virus antibodies also showed negative. Neither heavy alcohol consumption nor the intake of chemical drugs was observed before surgical resection.
Laser Capture Microdissection and RNA extraction
Four- micrometer sections of frozen liver tissues were not stained with any dye. The sections were immediately microdissected with a Leica AS LMD Laser Capture Microdissection System (Japan) using laser pulses of 7.5-μm diameters, 70 mW, and with 2–3 ms duration. Approximately 106 cells of human hepatocytes were microdissected and stored on microdissection caps with TRIZol reagent. Each cell population was determined to be 95% homogeneous by microscopic visualization of the captured cells. Laser-capture-microdissected hepatocytes were added to 1 ml TRIZol reagent (Invitrogen, Carlsbad, CA), and then total RNA was extracted according to the manufacturer's instructions and RNAse-free DNase I was used to remove DNA contamination. The nucleotide acid concentration and purity were assessed at 260 nm using a spectrophotometer (DU 530, Beckman-Coulter Inc., Fullerton, CA), and the quality was assessed by an Agilent 2100 Bioanalyzer. In addition, for the purposes of considering gene expression polymorphism, the total RNAs from ten livers were pooled equally.
MPSS was performed using RNA from the pooled livers and evaluated for the presence of LZP markers and absence of markers for AFP. The mRNA was converted to cDNA and digested with DpnII. The last DpnII site and the downstream 14 bases were cloned into Megaclone vectors and their sequences determined according to the MPSS protocol. This experiment was carried out by TaKaRa Co., Japan.
Semi-quantitative Reverse Transcription PCR
Reverse Transcription (RT) was performed in a 20 μl reaction system which contained 2 μg total RNA, 20 pmol oligo-dT, mixed up to 11 μl with DEPC-H2O and then incubated at 70°C for 5 minutes. After 5 mintues at 0°C, 4 μl 5 × buffer, 2 μl 0.1 M DTT, 2 μl dNTP (10 Mm) and 1 μl (200U) SurperScript II reverse transcriptase (Life Technologies), incubated at 42°C for 2 hours. In PCR, β-actin was used as a control to estimate the quality of cDNA (forward primer: 5'-TCACCCACACTGTGCCCATCTACGA-3' and reverse primer: 5'-CAGCGGAACCGCTCATTGCCAATGG-3'). To further avoid DNA contamination, all primers in this study were designed to span at least one exon. Each PCR was performed as follows: pre-denature at 94°C, 5 min; denature at 94°C, annealing at 55°C, extend at 72°C, 40 seconds, respectively, and finally at 72°C for 7 min. The PCR products were observed by electrophoresis on 2% agarose gel.
32 tissues for human transcriptomic analysis by MPSS were extracted from the NCBI GEO database (GPL1010). Genomic mapping data were taken from the human genome database version 17 at UCSC.
Availability and requirements
All data is available by download from our website http://184.108.40.206/hepatocytes/.
Massively Parallel Signature Sequencing
Laser Capture Microdissection
Meyers BC, Tej SS, Vu TH, Haudenschild CD, Agrawal V, Edberg SB, Ghazal H, Decola S: The Use of MPSS for Whole-Genome Transcriptional Analysis in Arabidopsis. Genome Research. 2004, 14 (8): 1641-1653. 10.1101/gr.2275604.
Brenner S, Johnson M, Bridgham J, Golda G, Lloyd DH, Johnson D, Luo S, McCurdy S, Foy M, Ewan M: Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat Biotechnol. 2000, 18 (6): 630-634. 10.1038/76469.
Jongeneel CV, Iseli C, Stevenson BJ, Riggins GJ, Lal A, Mackay A, Harris RA, O'Hare MJ, Neville AM, Simpson AJ, Strausberg RL: Comprehensive sampling of gene expression in human cell lines with massively parallel signature sequencing. Proc Natl Acad Sci USA. 2003, 100 (8): 4702-4705. 10.1073/pnas.0831040100.
Meyers BC, Vu TH, Tej SS, Ghazal H, Matvienko M, Agrawal V, Ning J, Haudenschild CD: Analysis of the transcriptional complexity of Arabidopsis thaliana by massively parallel signature sequencing. Nat Biotechnol. 2004, 22 (8): 1006-1011. 10.1038/nbt992.
Brandenberger R, Khrebtukova I, Thies RS, Miura T, Jingli C, Puri R, Vasicek T, Lebkowski J, Rao M: MPSS profiling of human embryonic stem cells. BMC Dev Biol. 2004, 4: 10-10. 10.1186/1471-213X-4-10.
Jongeneel CV, Delorenzi M, Iseli C, Zhou D, Haudenschild CD, Khrebtukova I, Kuznetsov D, Stevenson BJ, Strausberg RL, Simpson AJ, Vasicek TJ: An atlas of human gene expression from massively parallel signature sequencing (MPSS). Genome Res. 2005, 15 (7): 1007-1014. 10.1101/gr.4041005.
Smith AD, Sumazin P, Xuan Z, Zhang MQ: DNA motifs in human and mouse proximal promoters predict tissue-specific expression. Proc Natl Acad Sci USA. 2006, 103 (16): 6275-6280. 10.1073/pnas.0508169103.
Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, Volkert TL, Schreiber J, Rolfe PA, Gifford DK, Fraenkel E, Bell GI, Young RA: Control of pancreas and liver gene expression by HNF transcription factors. Science. 2004, 303 (5662): 1378-1381. 10.1126/science.1089769.
Krivan W, Wasserman WW: A predictive model for regulatory sequences directing liver-specific transcription. Genome Res. 2001, 11 (9): 1559-1566. 10.1101/gr.180601.
Terryn N, Rouze P: The sense of naturally transcribed antisense RNAs in plants. Trends Plant Sci. 2000, 5 (9): 394-396. 10.1016/S1360-1385(00)01696-4.
Vanhee-Brossollet C, Vaquero C: Do natural antisense transcripts make sense in eukaryotes?. Gene. 1998, 211 (1): 1-9. 10.1016/S0378-1119(98)00093-6.
Lehner B, Williams G, Campbell RD, Sanderson CM: Antisense transcripts in the human genome. Trends Genet. 2002, 18 (2): 63-65. 10.1016/S0168-9525(02)02598-2.
Li YY, Qin L, Guo ZM, Liu L, Xu H, Hao P, Su J, Shi Y, He WZ, Li YX: In silico discovery of human natural antisense transcripts. BMC Bioinformatics. 2006, 7: 18-26. 10.1186/1471-2105-7-18.
Chen J, Sun M, Kent WJ, Huang X, Xie H, Wang W, Zhou G, Shi RZ, Rowley JD: Over 20% of human transcripts might form sense-antisense pairs. Nucleic Acids Res. 2004, 32 (16): 4812-4820. 10.1093/nar/gkh818.
Yelin R, Dahary D, Sorek R, Levanon EY, Goldstein O, Shoshan A, Diber A, Biton S, Tamir Y, Khosravi R, Nemzer S, Pinner E, Walach S, Bernstein J, Savitsky K, Rotman G: Widespread occurrence of antisense transcription in the human genome. Nat Biotechnol. 2003, 21 (14): 379-386. 10.1038/nbt808.
Kumar M, Carmichael GG: Antisense RNA: function and fate of duplex RNA in cells of higher eukaryotes. Microbiol Mol Biol Rev. 1998, 62 (4): 1415-1434.
Knee R, Murphy PR: Regulation of gene expression by natural antisense RNA transcripts. Neurochem Int. 1997, 31 (3): 379-392. 10.1016/S0197-0186(96)00108-8.
Hastings ML, Milcarek C, Martincic K, Peterson ML, Munroe SH: Expression of the thyroid hormone receptor gene, erbAalpha, in B lymphocytes: alternative mRNA processing is independent of differentiation but correlates with antisense RNA levels. Nucleic Acids Res. 1997, 25 (21): 4296-4300. 10.1093/nar/25.21.4296.
Peters NT, Rohrbach JA, Zalewski BA, Byrkett CM, Vaughn JC: RNA editing and regulation of Drosophila 4f-rnp expression by sas-10 antisense readthrough mRNA transcripts. RNA. 2003, 9 (6): 698-710. 10.1261/rna.2120703.
Tufarelli C, Stanley JA, Garrick D, Sharpe JA, Ayyub H, Wood WG, Higgs DR: Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat Genet. 2003, 34 (2): 157-165. 10.1038/ng1157.
Chen J, Sun M, Hurst LD, Carmichael GG, Rowley JD: Genome-wide analysis of coordinate expression and evolution of human cis-encoded sense-antisense transcripts. Trends Genet. 2005, 21 (6): 326-329. 10.1016/j.tig.2005.04.006.
This work was supported by the Chinese Human Liver project (CNHLPP, 2004BA711A19), the National Natural Science Foundation for Outstanding Youth (30425019), the Chinese National Key Program on Basic Research (2006CB0D0802, 2004CB518605, 2006CB0D1205), the Chinese High-Tech Research and Development Program (863), the National Foundation for Excellence Doctoral Project, and the Shanghai Commission for Science and Technology (06ZR14069, 04XD14014 and 03DZ14024). We thank InforSense Ltd. for providing the KDE platform for the data analysis. We also thank Dr. Alex Michie in InforSense Ltd and Dr. Daixing Zhou in Solexa Company for the revision of this manuscript. In addition, we thank that TaKaRa Co. in Japan for performing MPSS experiment.
JH and ZGH designed the research pipeline. YLZ, FXD, QD and WY carried out the PCR experiments. YH and HYW captured human hepatocytes using LCM technique, JH, PH, XWW, XGZ and TTL performed the statistic analysis. JH, PH and ZGH drafted the manuscript. YXL, PYY and HYW participated in the design of the study. ZGH conceived and oversaw the research. All the authors read and approved the final manuscript.
Jian Huang, Pei Hao, Yun-Li Zhang contributed equally to this work.
Electronic supplementary material
Additional File 8: List of both sense and antisense transcripts co-expressed in human hepatocytes and mouse liver (XLS 42 KB)
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Huang, J., Hao, P., Zhang, YL. et al. Discovering multiple transcripts of human hepatocytes using massively parallel signature sequencing (MPSS). BMC Genomics 8, 207 (2007). https://doi.org/10.1186/1471-2164-8-207
- Human Hepatocyte
- Antisense Transcript
- Laser Capture Microdissection
- Massively Parallel Signature Sequencing
- UniGene Cluster